Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

NCT00034151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: S-8184 Paclitaxel Injectable Emulsion

Sponsor

Achieve Life Sciences